摘要
目的:观察马来酸多潘立酮片治疗功能性消化不良(FD)的疗效和安全性.方法:采用随机、双盲、双模拟、阳性药对照、多中心设计.研究对象为141例FD病人,年龄18~65 a,治疗组(63例)口服马来酸多潘立酮片,12.72 mg,tid;对照组(69例)口服多潘立酮,10 mg,tid,疗程均为4 wk.评价指标有症状评分、胃排空功能、临床症状总积分以及不良反应等.结果:用药2,4 wk后,2组病人主要症状积分均有显著下降(P<0.05或P<0.01).治疗组用药后早饱、腹胀、恶心、呕吐、上腹部疼痛、食欲不振、烧心和嗳气等8项主要症状的有效率分别为85%,89%,90%,90%,86%,81%,81%和86%;对照组分别为87%,93%,91%,82%,66%,81%,92%和94%,2组比较均无显著差异(P>0.05),2组病人均无严重不良反应.结论:马来酸多潘立酮片治疗FD安全、有效.
AIM :To evaluate the clinical efficacy and safety of domperidone maleate in the treatment of functional dyspepsia. METHODS:A total of 141 patients with functional dyspepsia were randomly divided into two groups. Testing group of 63 patients was treated with domperidone maleate 12.72 mg, po, tid for 4 wk and control group of 69 patients was treated with domperidone 10 mg, po, tid for 4 wk. RESULTS:In the testing group, the total effective rates of domperidone maleate in treating early satiety, epigastric fullness, nausea, vomiting, epigastric pain, decrease of food intake, heartburn and belch were respectively 85 % ,89 % ,90 % ,90 % ,86 % ,81%, 81% and 86 % ; and those were 87 % ,93 % ,91% , 82 % ,66 % ,81% ,92 % and 94 % ,respectively in control group. The differences in effective rates of clinical symptoms and gastric emptying between two the groups were insignificant ( P 〉 0. 05 ). CONCLUSION :Domperidone maleate is an efficacious and reliable agent in the treatment of functional dyspepsia.
出处
《中国新药与临床杂志》
CAS
CSCD
北大核心
2005年第9期697-700,共4页
Chinese Journal of New Drugs and Clinical Remedies
关键词
多潘立酮
消化不良
胃排空
临床试验
Ⅱ期
多中心研究
双盲法
随机对照试验
马来酸多潘立酮
domperidone
dyspepsia
gastricemptying
clinical trials, phase Ⅱ
multicenter studies
double-blind method
randomized controlled trials
domperidone maleate